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ABSTRACT:Cytochrome c (Cytc) plays avital role in themitochondrial electron transport chain (ETC). Inaddition, it is
a key regulator of apoptosis. Cytc has multiple other functions including ROS production and scavenging, car-
diolipin peroxidation, andmitochondrial protein import. Cytc is tightly regulated by allostericmechanisms, tissue-
specific isoforms, and post-translational modifications (PTMs). Distinct residues of Cytc are modified by PTMs,
primarily phosphorylations, in a highly tissue-specific manner. These modifications downregulate mitochondrial
ETC flux and adjust the mitochondrial membrane potential (DCm), to minimize reactive oxygen species (ROS)
production under normal conditions. In pathologic and acute stress conditions, such as ischemia–reperfusion,
phosphorylations are lost, leading to maximum ETC flux, DCm hyperpolarization, excessive ROS generation, and
the release ofCytc. It is also the dephosphorylated formof theprotein that leads tomaximumcaspase activation.We
discuss the complex regulationofCytc andpropose that it is a central regulatory stepof themammalianETC that can
be rate limiting in normal conditions. This regulation is important because itmaintains optimal intermediateDCm,
limiting ROS generation.We examine the role of Cytc PTMs, including phosphorylation, acetylation, methylation,
nitration, nitrosylation, and sulfoxidation and consider their potential biological significance by evaluating their
stoichiometry.—Kalpage,H.A., Bazylianska,V., Recanati,M.A., Fite,A., Liu, J.,Wan, J.,Mantena,N.,Malek,M.H.,
Podgorski, I., Heath, E. I., Vaishnav, A., Edwards, B. F., Grossman, L. I., Sanderson, T. H., Lee, I., Hu¨ttemann, M.
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Cytochrome c (Cytc) plays a pivotal role in making life-
and-death decisions for the fate of the cell. It is a small,
globular, highly conserved, 104 aa protein with a co-
valently attached heme group that performs multiple
functions and catalytic activities. In the mitochondrial
electron transport chain (ETC), Cytc acts as an electron
carrier from complex III to complex IV, which are also
known as the cytochrome bc1 complex and Cytc oxidase
(COX), respectively. ETC function fully relies on the
presenceofCytc, as canbe seen inCytc-knockoutmice that
die at midgestation (1), when fetal metabolism switches
fromglycolysis to oxidative phosphorylation (2) to sustain
the increasing energy supply of the growing organism. It
has been shown with Cytc knockout mouse fibroblasts
that Cytc plays a prominent role in supercomplex forma-
tion and is essential for the stability and assembly of COX
(3). Cytc also plays a key role in apoptosis by acting as a
signaling molecule that is released from themitochondria
into the cytosol during cellular stress. In the cytosol, it
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interactswith apoptosis activating factor (Apaf)-1, leading
to the formation of the heptameric apoptosome, which
activates downstream caspases and initiates the cell death
pathway. Furthermore, early-on during apoptosis, Cytc
functions as a peroxidase of cardiolipin, a mitochondria-
specific lipid that binds to Cytc. This interaction leads to
conformational changes around the heme group, con-
verting Cytc into a pentacoordinated structure from its
native hexacoordinated form (4, 5). This conversion
enhances cardiolipin peroxidase activity of Cytc in the
presence ofH2O2. This proapoptotic event promotes the
dissociation of Cytc from the outer leaflet of the inner
mitochondrial membrane and its release into the cyto-
sol, where apoptosis is induced (6). There are 2 distinct
binding sites for cardiolipin: the A and C sites. The A
site overlapswith theATP binding site, which is located
on the left side of themolecule in the conventional view.
The C site allows hydrophobic interaction between car-
diolipin and Cytc (7, 8).
Cytc has been referred to as a “moonlighting” protein
because of its multifunctional properties in addition to
apoptosis and respiration (9, 10). It has been shown toplay
a role in regulated production of reactive oxygen species
(ROS), mainly H2O2, by reducing p66
Shc (11), a splice
variant of p52Shc/p46Shc, which are adaptor proteins in-
volved in the Ras signaling pathway (12). p66Shc is a neg-
ative regulator of life span with increased survival
observed in p66Shc knockoutmice and cells (13–15). These
knockouts also demonstrate increased resistance to ROS
and UV damage. p66Shc is regulated by phosphorylation
through the PKC-b signaling pathway (16). Phosphory-
lation of p66Shc at Ser36 is necessary for its role in ROS
production (13, 17, 18). Prevention of Cytc binding by
mutation of p66Shc W134F has been shown to attenuate
ROS-induced renal toxicity (19–21).
In contrast to the role of Cytc in regulated ROS forma-
tion by interaction with p66Shc, Cytc is also a well-known
ROS scavenger because of its ability to take up and donate
electrons quickly. Horse heart Cytc has been shown to act
as an H2O2 scavenger in rat heart mitochondria linked to
reverse electron transfer from succinate to NAD+ in-
volving complex I (22, 23). In addition, Cytc plays a role in
oxidation of superoxide to oxygen, where the electron re-
moved from superoxide is channeled toCOXandused for
energy production (22, 24). Recently, Cytc was shown to
function as anH2S oxidase and thus as amodulator ofH2S
signaling (25).
Cytc also has a rodent testes-specific isoform that is 86%
homologous to the somatic form (26). It has been shown
that testes-specific Cytc results in 3 times better H2O2
scavenging compared to somatic Cytc. However, the
testes-specific Cytc also demonstrates significantly higher
apoptotic activity, possibly to help maintain sperm in-
tegrity (27). In humans, this testes-specific isoform exists
as a nontranscribed pseudogene (28, 29). The loss of the
testes-specific isoform in humans may at first sight be sur-
prising. However, the loss—engendered by a stop codon
at position 49—took place on the primate stem ;65 mil-
lion years ago (30). The loss of the testes isoformcoincided
with a period of accelerated evolution of COX in anthro-
poid primates, such that the COX acceleration was much
greater for the residues that are part of the Cytc-COX
binding domain than at other COX residues (31). The
result is that COX has undergone several amino acid
replacements, leading to reduced electrostatic interactions
between these 2 proteins in anthropoid primates (31).
In conjunction with its potential as an electron carrier,
Cytc is also involved in redox-coupled import of pro-
teins containing twin CX3C and CX9C proteins through
the Mia40-Erv1 disulfide relay system. These cysteine-
rich proteins are transported to the intermembrane space
of the mitochondria via Mia40-catalyzed oxidation of
the 4 cysteine residues of the proteins that enter the in-
termembrane space through the translocase of the outer
membrane proteins. Mia40 is reoxidized by sulfhydryl
oxidase Erv1, and Erv1 is reoxidized by transfer of elec-
trons to Cytc, thus connecting this protein import path-
way to the ETC (32, 33).
Cytc has also been reported to bind the inositol-1,4,5-
triphosphate receptor in the endoplasmic reticulum dur-
ing apoptosis, which leads to calcium overload in the
mitochondria and cytosol, resulting in a positive-feedback
mechanism that causes more Cytc release and activation
of apoptosis (34–36). In addition, once released, Cytc
competes with the Apaf-1 inhibitor 14-3-3e for binding
to Apaf-1, further promoting caspase activation (37).
Furthermore, Cytc acts as an oxidizing agent that fa-
cilitates conversion of sulfite to sulfate by sulfite oxi-
dase, a molybdenum-dependent mitochondrial protein
(38, 39). Sulfite is a harmful metabolic byproduct of the
amino acids containing sulfur, methionine and cyste-
ine. Cytc helps reduce sulfite toxicity by interaction
with sulfite oxidase in a binding domain similar to that
of COX (40).
Cytc can translocate to the nucleus in response to DNA
damage, where it has been shown to play a role in apo-
ptosis by inducing chromatin condensation independent
of caspase activity (41). Other studies have suggested that
nuclear translocation of Cytc takes place before caspase
activation. Human Cytc and plant Cytc inhibit the nucle-
osome assembly function of SET/template-activating
factor Ib (SET/TAF-Ib) chaperones in humans and nucle-
osome assembly protein-1–related protein-1 (NRP-1)
chaperones in plants (42, 43). Cytc is a highly positively
charged protein that promotes its interaction with low-
complexity acidic regions of the above histone-binding
chaperones. This inhibitory interaction of Cytc has been
proposed to be a cellular life-or-death mechanism, depend-
ing on the severity of cell damage (44). Finally, Cytc
was recently shown to have yet another catalytic function
by acting as a plasmalogenase in vitro, cleaving the
vinyl–ether linkage of important phospholipids called
plasmalogens, which are involved in lipid signaling (45).
However, more research is needed to confirm that Cytc
acts as a plasmalogenase in vivo.
POST-TRANSLATIONAL MODIFICATIONS OF CYTc
AND THEIR FUNCTIONAL EFFECTS
Considering the multiple roles of Cytc in energy pro-
duction, ROS balance, and apoptosis (Fig. 1), this protein
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shouldbe tightly regulated. Regulation ofmitochondrial
proteins is also necessary because of the differences
in the cellular metabolic requirements between tissues
and organs. Protein regulation can be achieved by sev-
eral mechanisms, starting at the gene expression level,
through translational regulation, and finally at the post-
translational level through post-translational modifi-
cations (PTMs) and protein turnover. In multicellular
organisms, cell signaling through PTMs is one of the
most crucial regulatory pathways. Despite many years
of research on Cytc, the fact that it is a target of cell
signaling through PTMs was revealed only recently. In
this review we focus on the published literature of Cytc
modifications such as phosphorylations, methylations,
acetylations, nitrations, nitrosylations, and sulfoxidations
(Table 1). A guiding theme of this review is that the bi-
ologic consequences of PTMs should be interpreted with
respect to howmuch of the entire protein pool contains a
particular modification. This information is critically
important but is missing in most studies. Despite major
methodological advances in mapping PTMs to specific
residues of a protein, primarily by mass spectrometry,
which has become increasingly sensitive, quantitative
information is often lacking. If, for example, only 1% of a
metabolic enzyme carries a PTM, it is most likely ad-
ventitious and unlikely to have a biologic effect. Even
Western blot analysis with PTM-specific antibodies can
only estimate a relative increase or decrease of the mod-
ification, and the same issue remains, despite the often-
reportedseveral-fold increase in signal. This point is often
overlooked, not just in studies related to mitochondria,
but also inpublications related to cell signaling ingeneral.
CYTc PHOSPHORYLATION
Most reports that studied functional effects of PTMs
focused on Cytc phosphorylation. Protein phosphoryla-
tion and dephosphorylation are critical cell-signaling
mechanisms essential for many cellular functions. In the
past,mitochondriawereviewed as relatively independent
organelles, and not much interest was paid to their regu-
lation by cell signaling. Despite the fact that there are a
few long-known examples demonstrating that mitochon-
drial metabolism is decisively regulated via PTMs, such
as the pyruvate dehydrogenase complex by pyruvate de-
hydrogenase kinases, which was discovered ;50 yr ago
(46), only recently have mitochondria been recognized as
hubs for cell signaling. At the level of the ETC, .100
phosphorylation sites have been mapped, but the func-
tions of most of them remain unknown (47). Of the few
sites with a known function, most have been reported for
Cytc and its partner COX. Examples for COX include
subunit I phosphorylation of Tyr304 mediated by the
cAMP-dependent andTNF-a pathways (48, 49), andCOX
subunit II phosphorylation by Src kinase and receptor
tyrosine kinases EGFR and ERBB2, although the sites
remain unknown (50–52). On mammalian Cytc, 4 phos-
phorylation sites have been mapped by mass spectrome-
try. These are Tyr97, Tyr48, Thr28, and Ser47, which
appear to be present in a highly tissue-specific manner
and are discussed below in the sequence of their identifi-
cation. All 4 sites are located on the right side of the mol-
ecule in theconventionalview (Fig. 2) andare conserved in
mammals (Fig. 3).
Tyr97 phosphorylation
In 2006, our lab reported for the first time thatmammalian
Cytc is phosphorylated in vivo (53). Cytcwas isolated from
bovine heart under conditions that preserve in vivo phos-
phorylation in the presence of the phosphatase inhibitor
vanadate, a nonspecific tyrosine phosphatase inhibitor;
fluoride, a nonspecific serine/threonine phosphatase in-
hibitor; and EGTA, a calcium chelator that prevents the
activation of calcium-dependent protein phosphatases.
Analysiswith immobilizedmetal affinity chromatography/
nanoliquid chromatography/electrospray ionizationmass
spectrometry (IMAC/nano-LC/ESI-MS) showed that
Tyr97 is phosphorylated. Spectral analysis of the protein
showeda shift of the characteristic 695nmpeak to687nm,
which was reversed by alkaline phosphatase treatment,
Figure 1. Pro-life (green arrows)
and pro-death functions (red
arrows) of Cytc.
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indicating that the shift is due to phosphorylation. The
695 nm absorption band results from the heme Fe-S
(Met80) bond, and a shift suggests a conformational
change in the heme environment that potentially affects
its function. The absence of the 695 nmpeak is pathologic
because it suggests a misfolded, dysfunctional confor-
mation of Cytc (54).
The in vivo phosphorylated Cytc demonstrated sig-
moidal kinetics in the reaction with COX, as compared
with the phosphatase-treated dephosphorylated Cytc,
which produced a hyperbolic response, shifting the Km
value of COX for Cytc from 5.5 to 2.5 mM. This finding
indicates that phosphorylation leads to an inhibition of the
reaction with COX when Cytc concentrations are not sat-
urated.However,maximumturnoverwas similar forboth
the phosphorylated and nonphosphorylated forms of the
protein (53). The differences in enzyme kinetics and spec-
tral changes indicate that phosphorylation of Tyr97, lo-
cated on the opposite site of the heme crevice (Fig. 2),
affects the function of the enzyme.
Tyr97 is located in a relatively hydrophobic area in
Cytc, called the “right channel,” which contributes to
the interaction with lipids (55). The location of Tyr97
between this channel and the heme moiety could pro-
vide a pathway for electron transfer when Cytc func-
tions as a cardiolipin peroxidase. Previously identified
phosphorylation sites—Tyr304 on subunit I of COX (48,
49) and Tyr97 in cow heart Cytc—share a similar se-
quencemotif, and this phosphoepitope is unique to Cytc
and the COX subunit I in the ETC, suggesting that both
sites are targeted by the same kinase/phosphatase. Cytc
Lys7, a key residue involved in apoptosome formation,
is located next to Tyr97 (56). The effect of Tyr97 phos-
phorylation on apoptosis has not yet been analyzed.
However, Tyr97 phosphomimetic Cytc showed only a
small reduction in caspase-9 activity in vitro (57, 58).
Another study showed that Tyr97 is phosphorylated
in the brain after neuroprotective treatment with
insulin in the context of brain ischemia–reperfusion
injury (59). The study also showed that Cytc is not
TABLE 1. Identiﬁed PTMs of Cytc
Site Modiﬁcation Methodology Tissue/condition Primary functional effect Reference
Lys8 Acetylation High-throughput
Nano-HPLC/
MS/MS
Mouse liver mitochondria
(unfed state)
Not tested 112
Thr28 Phosphorylation ESI-MS/MS Bovine kidney Lower respiration, membrane
potential, and ROS
76
Human phosphomimetic 77
High-throughput
LC-MS/MS
Human muscle (resting
state)
Not tested 74
Human muscle (after
exercise)
Not tested 75
Ser47 Phosphorylation High-throughput
LC-MS/MS
Human muscle (resting
state)
Not tested 73, 74
Human muscle (after
exercise)
Not tested 75
Human phosphomimetic Lower caspase activity 77
Tyr48 Phosphorylation IMAC/nano-
LC/ESI-MS
Bovine liver Lower COX activity, abolished
caspase-3 activity, and lower
cardiolipin peroxidase
activity
62, 66
Tyr67 Nitration ESI-MS Horse heart (peroxynitrite
treatment); osteoclasts
Reduced mitochondrial
respiration
135, 137
Lys72 (yeast
numbering)
Trimethylation Radioactive
labeling
Fungi/plants Helps Cytc import into the
mitochondria, prevents
apoptosis, and improves
protein stability against
proteolytic degradation
98, 102, 103,
152, 153
Tyr74 Nitration MALDI-TOF-MS Recombinant human
(peroxynitrite
treatment)
Increased cardiolipin
peroxidase activity and
suppressed caspase-9 activity
124
Met80 Nitrosylation EPR spectroscopy Horse heart (reaction
with NO)
Increased cardiolipin
peroxidase activity
142, 143
Met80 Sulfoxidation MALDI-TOF-MS Horse heart (oxidative
stress)
Increased cardiolipin
peroxidase activity
118, 139
Tyr97 Phosphorylation IMAC/nano-LC/
ESI-MS
Bovine heart; porcine
brain (after insulin
treatment)
Lower COX activity; reduced
Cytc release and apoptosis
after ischemia/reperfusion
when treated with insulin
53, 59
ESI-MS/MS, electronspray ionization MS/MS; EPR, electron paramagnetic resonance; HPLC/MS/MS, high-performance liquid chro-
matography tandem mass spectrometry; MALDI-TOF-MS, matrix-assisted laser desorption ionization-time of ﬂight-MS.
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phosphorylated after global brain ischemia, but for
brain Cytc, the basal phosphorylation state remains
unknown. Insulin-treated rats showed an increase in
neuronal survival and reduction of Cytc release from
the mitochondria, suggesting that insulin-mediated
Tyr97 phosphorylation is a mechanism that limits ap-
optotic cell death during ischemia-reperfusion (59, 60).
These findings are consistent with our model (Fig. 4),
proposing that Cytc is phosphorylated under normal
physiological conditions. During stress, Cytc becomes
dephosphorylated, which allows maximum flux in the
ETC. However, in the context of ischemia, absence of
oxygen leads to a cellular energy crisis, and the ETC
becomes primed for hyperactivity, but because of the
lack of its terminal substrate, oxygen, the ETC can re-
sume function only when blood flow is restored to the
ischemic tissue, leading to mitochondrial membrane
potential (DCm) hyperpolarization and excessive ROS
production at complexes I and III, which initiates the
apoptotic cascade.
Tyr48 phosphorylation
This sitewas firstmappedonCytcpurified fromcow liver.
Both Tyr48 and Tyr97 are conserved in mammals (Fig. 3)
and eukaryotes in general (61), in which tyrosine phos-
phorylation is an important regulatory mechanism in
many processes ranging from hormone responses, to
cellular growth, to metabolism. Tyr48 phosphorylation
resulted in a;50% decrease in maximum turnover when
analyzedwithcowliverCOX(62).This result suggests that
Tyr48 phosphorylation has a more profound impact on
controlling COX activity of Cytc than does Tyr97. Tyr97
phosphorylation produced sigmoidal kinetics, however,
maximum turnover rates were similar for the phosphor-
ylated and nonphosphorylated forms (53, 62). In contrast,
Tyr48 phosphorylated Cytc produced hyperbolic kinetics.
Tyr48 is located on the lower median frontal area of the
molecule in proximity to the heme crevice (Fig. 2). It is also
important to note that Tyr48 is located in the 40–57V loop,
which requires the least free energy to beunfolded (63, 64).
Both Tyr48 and Tyr97 residues showed NMR signal in-
tensity changes after cardiolipin binding, whereas Tyr67
and Tyr74 did not, suggesting that changes in Tyr48 and
Tyr97 more strongly affect the molecular dynamics of
Cytc (65).
Figure 2. Tissue-speciﬁc phosphorylation sites are located on
the right side of Cytc, whereas cardiolipin and ATP binding sites
are located on the left side. Crystallographic data from oxi-
dized rat Cytc were used (76) and analyzed with the molecular-
graphics, -modeling and -simulation program YASARA (http://
www.yasara.org/). Cytc is shown in the conventional view. The
heme group is shown in red, and amino acids known to be
phosphorylated in a tissue-speciﬁc manner are highlighted in
yellow, together with the organs in which they have been
identiﬁed under baseline condition. Amino acids implicated in
ATP binding are Lys88, Arg91, and Glu62 (150) and are shown
in green. Residues involved in cardiolipin binding are Lys87,
Lys86, Lys73, Lys72 (A site), and Asn52 (C site) (5) and are
shown in magenta. A third site for electrostatic interaction of
Cytc with phospholipids consists of Lys22, Lys25, Lys27, His26,
and His33 (151).
Figure 3. Sequence alignment of Cytc with highlighted post-translational modiﬁcations identiﬁed in mammals in vivo. Top,
somatic Cytc from selected mammalian species with matching sequences of the corresponding testes-speciﬁc isoforms (T) where
available (bottom). Note that humans express only a single ubiquitous Cytc (middle), which shares sequence homology with the
somatic and testis isoforms. Ac, acetylation; P, phosphorylation. Met80 of the heme group shown in red is likely involved in
sulfoxidation and nitrosylation as a result of nitro-oxidative stress. UniProt (https://www.uniprot.org/) Protein sequence accession
numbers were F7D4V9 (horse); P62894 (bull); P62895 (pig); A0A0C4Y1X3 (goat); P00011 (dog); P62897 (mouse); P62898 (rat);
S7QBN9 (bat); I6VH08 (dolphin); P99999 (human); Q3SZT9 (bull testes); P00015 (mouse testes); and P10715 (rat testes).
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The functional effects of Tyr48 phosphorylation were
further characterized by generation of a phosphomimetic
Cytc mutant, Tyr48Glu, which carries a negative charge
similar to that of the phosphate group, and a control mu-
tant Tyr48Phe, which cannot be phosphorylated on this
site. Similar to in vivo Tyr48 phosphorylation, the phos-
phomimetic Tyr48Glu mutant showed a reduced maxi-
mum turnover rate compared to the wild type (WT),
suggesting that it is a useful model (66). The reduction of
maximum turnover in the reaction with COX was less
pronounced with heart COX than with liver COX, most
likely because of the presence of 3 heart-specific COX
subunit isoforms (VIa-H, VIIa-H, and VIII-H) (67). Fur-
thermore, a higher Km was observed, suggesting a lower
binding affinity toward heart COX (66). In addition to the
commonly used glutamate and aspartate replacements to
simulate phosphorylation, Guerra-Castellano et al. (68)
recently introducedp‐carboxymethyl‐L‐phenylalanineasa
replacement for tyrosine residues that can be phosphory-
lated. This substitution not only introduces a negative
charge similar to glutamate and aspartate, it also better
mimics the tyrosine side chain spatially, because of the
presence of the phenyl ring.
The phosphomimetic Tyr48Glu substitution resulted in
a lower redox potential by 45mV, possibly because of the
perturbation of the heme crevice and stabilization of the
iron in its oxidized state.Amidpoint redoxpotential lower
than that of cytochrome c1 in the bc1 complex suggests that
Tyr48 phosphorylation controls and reduces the electron
transfer rate ofCytc at the bc1 complex.This reductionmay
cause Cytc to take part in other functions such as ROS
scavenging (24). The phosphomimetic Tyr48Glu Cytc
demonstrated significant effects on the apoptotic function
of Cytc by decreasing cardiolipin peroxidase activity and,
strikingly, by abolishingdownstreamcaspase-3 activation
(66). A study using the artificial phosphomimetic amino
acid, p-carboxymethyl phenylalanine, substituted for
Tyr48, showed an ;70% reduction in caspase 3 activity,
whereas cardiolipin peroxidase activity did not change
when data were normalized for baseline peroxidase ac-
tivity in the absence of cardiolipin (64). This study also
concluded that Tyr48pCMF Cytc reduces ETC activity
compared to WT protein.
Cytc mutations are very rare in humans and to date,
there are only 2knownaminoacidswith adisease-causing
mutation. The first reported mutation causes a Gly41Ser
replacement (69), which renders Cytcmore susceptible to
Met80 oxidation by H2O2, generating a Met80 sulfoxide
(70). The second reported mutation was Tyr48His in pa-
tients from an Italian family (63). Both substitutions cause
the same mild disease, thrombocytopenia, which is a con-
dition that results in lower blood platelet levels. In patients
with both Gly41Ser and Tyr48His mutant Cytc, mito-
chondriaweremorphologicallynormal, butplatelet counts
were reduced by about half. The replacement of Tyr48
by the positively charged histidine caused several func-
tional changes, including reduced oxygen consumption
rate and increased apoptosis (63). A recent study on the
Tyr48His variant showed that the pentacoordinated form
of Cytc, which promotes cardiolipin peroxidase activity,
is more prevalent in the mutant, further supporting the
increased apoptotic activity (71). Molecular dynamics
simulations concluded that both Gly41Ser and Tyr48His
mutations result in a less stable and more open protein
structure, which would promote cardiolipin peroxidase
activity (72).At this point, it is unclearwhy thesemutations
cause such a cell-type–specific phenotype. For the Tyr48-
His mutation it is even more surprising that no liver phe-
notype has been reported, because this mutation would
prevent liver Cytc from being Tyr48 phosphorylated and
consequently make liver cells more prone to apoptosis.
Thr28 phosphorylation
Thr28 was first identified as being phosphorylated in hu-
man skeletal muscle by a high-throughput phosphopro-
teomics study (73). An independent high-throughput
study of the same tissue detected Thr28 and Ser47 phos-
phorylation (74). Furthermore, in 2015 Hoffman and col-
leagues (75) found Thr28 and Ser47 phosphorylation in
Figure 4. A model of the connection of the phosphorylation
state of Cytc in the regulation of electron ﬂux in the ETC,
DCm, and ROS production. In normal conditions (middle)
Cytc is phosphorylated, which lowers electron ﬂux in the ETC,
maintaining healthy intermediate DCm levels, which are sufﬁ-
cient for effective ATP generation, but limit the production of
ROS that are generated exponentially at DCm levels exceeding
140 mV. During stress conditions, such as ischemia (left), the
tissue becomes energy depleted because of the lack of oxygen,
leading to dephosphorylation of Cytc and other mitochondrial
proteins. This occurrence renders the ETC primed for hyper-
activation. When the tissue is reperfused and oxygen re-enters
the cells, the ETC generates high DCm levels, leading to ROS
production and initialization of cell death cascades, adding to
the damage already generated during the ischemic phase.
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human skeletal muscle after exercise. However, no func-
tional experimentswere conducted in any of these studies.
We recently identified Thr28 phosphorylation in mam-
maliankidney (76).Over 80%of theCytcpool isolated from
bovine kidney carried this PTM, suggesting that it is
biologically relevant. Thr28-phosphorylated and recombi-
nant Thr28Glu phosphomimetic Cytc exhibited inhibition
of COX activity, by 50 and 73%, respectively. The finding
that phosphomimetic replacement leads to a more pro-
nounced effect may be explained by the presence of some
nonphosphorylated Cytc (;20%) when isolated from kid-
ney, whereas the recombinant phosphomimetic protein is
homogeneous. Additional cell culture experiments were
performed in WT and Thr28Glu Cytc transfected Cytc-
knockout mouse lung fibroblasts to further validate these
findings. The phosphomimetic Thr28Glu Cytc-expressing
cells showed lower intact cell respiration, DCm, and ROS
levels.Thesedata suggest thatmodificationofCytc controls
ETC flux and can prevent DCm hyperpolarization and
ROS production. This important discovery is the first in-
dication that aCytcPTMcan regulate the overall flux in the
ETC. It fits our model where, in normal conditions, the
activity of the ETC is downregulated or “controlled” to
prevent DCm hyperpolarization and consequent ROS
production (Fig. 4). Furthermore, AMPK has been identi-
fied as the mediator of this site-specific phosphorylation
by both in vitro and pharmacological approaches, making
it one of the few examples where a phosphorylation site
has been mapped with a larger fraction of the protein con-
taining the PTM, together with the kinase and functional
effects. In contrast toother tissues,AMPKhasahigherbasal
activity in kidney andmayaccount for the finding thatCytc
is phosphorylated under basal conditions in this organ.
Thr28 is present in a region of Cytc called the “negative
classical gamma turn” (residues 27–29; Figs. 2 and 3) lo-
cated near the heme crevice and is a part of the COX
binding domain of Cytc. Structural analysis of Cytc has
shown that the residues present in this turn have the
highest root-mean-square deviations of the whole Cytc
molecule, suggesting that this is the most flexible element
of the protein (76). However, Thr28 phosphorylation does
not have an impactonapoptosomeactivity, becauseThr28
is not part of theApaf-1 binding domain of Cytc (76, 77). It
would be interesting to analyze whether Cytc in skeletal
muscle is targeted by AMPK (74, 75) or a different kinase.
AMPK follows its more traditional role in muscle as an
energy sensor andmetabolic activator when energy levels
drop, and itmayseemcounterintuitive to trigger thisPTM,
which partially inhibits the ETC, when increased mito-
chondrial activity would be needed.
Ser47 phosphorylation
Ser47 phosphorylation of Cytc was also mapped in the
above phosphoproteomic studies of human skeletal
muscle along with Thr28 (74, 75), but it was not iden-
tified in a third study on the same tissue (73). In vitro
studieswithphosphomimetic Ser47AspCytc suggest that
it prevents caspase activity, opposite to the Thr28Asp
phosphomimetic substitution, suggesting that this site
is important for the regulation and execution of apo-
ptosis (77).
TISSUE-SPECIFIC REGULATION OF RESPIRATION
AND APOPTOSIS THROUGH REVERSIBLE
PHOSPHORYLATIONS: AN INTEGRATED MODEL
The fact that basal phosphorylations of Cytc are tissue
specific—Tyr97 in heart, Tyr48 in liver, and Thr28 in
kidney—may at first seem surprising. All 3 functionally
characterized phosphorylations lead to partial inhibition
of the reaction between Cytc and COX or “controlled res-
piration” (Fig. 4). Such a mechanism can help maintain
healthy intermediate levels of theDCm toprevent excessive
ROS generation that takes place at high membrane poten-
tials (DCm. 140 mV). Proper regulation of the membrane
potential is crucial because it is directly related to the pro-
ductionofROS. Ithasbeenshownexperimentally thatDCm
levels exceeding 140 mV lead to an exponential increase in
ROS production at ETC complexes I and III, whereas mi-
tochondria of resting cellswith an intermediateDCmdonot
produce significant amounts of ROS (78–80). Studies per-
formed in perfused rat hearts (81), lymphocytes (82), em-
bryonic heart cells (83), intact cultured fibroblasts, and
neuroblastoma cells (84) showed DCm values in the range
of 80–140mV,whichmay resemble the healthyphysiologic
DCm range in intact cells and organs under normal condi-
tions. These results are favorable because maintenance of
physiologically intermediate DCm values prevents exces-
sive ROS generation but provides the full capacity to pro-
duce ATP, because maximum ATP synthesis by ATP
synthase takes place at aDCm of 100–120mV (85). Because
the electron transfer reaction fromCytc toCOX to oxygen is
the proposed rate-limiting step of the ETC under physio-
logical conditions (86–90), it is not surprising that it is highly
regulated to prevent DCm hyperpolarization and ROS
generation under normal nonstressed conditions.
However, the situation is different with regard to apo-
ptosis, where some PTMs seem to affect apoptosome for-
mationanddownstreamcaspaseactivation,whereasothers
do not. It is noteworthy that Cytc Tyr48 phosphorylation
fully protects against caspase activation, as shown with
phosphomimetic Cytc (64, 66), whereas Thr28 phosphor-
ylation in kidney has no such effect. Liver cells are con-
stantly bombarded with molecules that the organism
takes up through the digestive system and even the lung
(91). Itmay therefore seemreasonable toaddanother layer
of protection, through Tyr48 phosphorylation, to prevent
apoptosis in the relatively toxic environment to which
liver cells are exposed. Other organs that are not in “di-
rect” contact with the environment and instead face a
mostly homeostatic milieu may not need an extra safe-
guarding mechanism.
CYTc METHYLATION
In histones, the e-NH2 group of lysine residues can be
mono-, di-, or trimethylated, and such modifications reg-
ulate many biological functions, such as gene regulation
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and signal transduction (92). In general, lysine, arginine,
histidine, anddicarboxylic amino acids are able to accept a
methyl group to their side chains. Methylation occurs in a
species-specific manner. In mammals, arginine and lysine
methylation are found, and inhumans theyoccur at a ratio
of ;4:1 for Arg:Lys (93). However, of the 18 lysine and
2 arginine residues present in human Cytc (Fig. 3), none
was found to be modified (93). As discussed below, Cytc
methylation appears to be important in some organisms
other than mammals, where it occurs on lysine residues.
Under physiological conditions the unmodified lysine
side chain amino group with a side-chain pKa of 10.5 is
protonatedand carries apositive charge,which is essential
for ionic interactions between a protein with other mole-
cules including proteins, DNA, RNA, and metabolites.
Addition of methyl groups further increases the pKa mod-
ifications of the e-amino group of lysine residues resulting
in a remarkable chemical diversity of ;20 different modi-
fications of this amino acid, including mono-, di-, and tri-
methylation, acetylation, and ubiquitination (94).
It has been shown in Saccharomyces cerevisiae and in
plants that apocytochrome c expressed from the CYC1
gene is immediately trimethylated by the Cytc methyl-
transferase Ctm1p in the cytosol at an evolutionarily
conserved site, Lys78, often referred to as Lys72, based on
the corresponding homologous residue in vertebrates
(95–97). Functionally, it has been shown that the import
of methylated yeast Cytc into yeast mitochondria is
much greater than the import of nonmethylated Cytc (98).
However, this effect was not observed with rat liver
mitochondria. It is possible that in yeast Cytc is imported
into the mitochondria through a methylation-dependent
receptor mechanism. Earlier work showed that, in the
fungus class Ascomycetes, methylation of Cytc Lys72
maintains the binding of the hemoprotein to mitochon-
dria and the researchers concluded that methylation of
the protein is essential for its physiological functions, in-
cluding electron transport through the ETC (99). More
recently, it has been demonstrated that methylation of
yeast Cytc (Cyc1p) increases its interactions with Erv1p
and the Cytc heme lyase Cyc3p, further supporting the
role of methylation in the import of apocytochrome c to
yeast mitochondria (100). Metazoan Cytc, methylated at
Lys72 after expression in yeast, completely prevented
proapoptotic activity of Cytc by lowering the binding af-
finity toward Apaf-1 (101).
Structurally,methylation of yeast Lys-72Cytc increases
protein stability in vivo against proteolytic degradation
(102, 103) and may modulate its geometry, isoelectric
point, or conformation (104–106). In addition, a structural
analysis demonstrated that trimethyllysine 72 is posi-
tioned near the heme crevice loop (V loop D, residues
70–85) and plays a crucial role in opening the crevice,
suggesting a potential role in regulating peroxidase
activity during apoptosis (107).
CYTc ACETYLATION
Acetylationof lysine side chains is another important PTM
catalyzed by lysine acetyltransferases that use acetyl-CoA
asa substrate for transfer of its acetylmoiety to the e-group
of a lysine residue. Acetylation also occurs nonenzymati-
cally, especially in the mitochondrial matrix where high
acetyl-CoA concentrations and a more basic pH favor the
transfer of the acetyl group andmake it themost prevalent
PTM (94). Recent studies have confirmed that the mito-
chondrial proteome is highly acetylated, with more than
60% of proteins analyzed having 1 or more acetylation
sites (108–111). Lysine acetylation leads to neutralization
of the positive charge related to amide bond formation,
increasing hydrophobicity, and spatial layout of the lysine
side chain. In vitro acetylation of horse heart Cytc was
shown to abolish the H2O2 scavenging function of Cytc
(22). The only reported in vivo acetylation site of mam-
malianCytc is Lys8 (Fig. 3),whichwas identified in ahigh-
throughputproteomics study inmouse livermitochondria
when animals were unfed but not when they were fed
(112). The extent of acetylation, the functional effect, and
specificity—enzymatic vs. nonenzymatic acetylation—
remain unknown.
CYTc SULFOXIDATION
H2O2 is one of the main reactive oxygen species involved
in oxidative stress.One establishedmodification ofCytc in
response to increased oxidative stress is Met80 sulfox-
idation (5). Cytc, when bound to cardiolipin, is more ac-
cessible to H2O2. Another characteristic change in Cytc
upon cardiolipin binding is a significant negative shift in
the redox potential (350–400mV) (113). Typically, a redox
potential in the range of 220–270 mV is observed for Cytc
inmammals (114, 115). The shift in redox potential caused
by cardiolipin binding suggests that it is thermodynami-
callyunfeasible for cardiolipin-boundCytc to engage as an
efficient electron carrier in the ETC. Furthermore, it makes
Cytc incapable of acting as a ROS scavenger (113). In
Cytc–cardiolipin complexes, submillimolar H2O2 concen-
trations oxidize the sulfur atom of the Met80 axial ligand.
Therefore, Met80 sulfoxidation of Cytc significantly en-
hances peroxidase activity ofCytc, promotingCytc release
and apoptosis (116, 117).
Cytc sulfoxidation isdifficult todetect and study in vivo.
However, Wang et al. (118) functionally studied this
modification by creating a mutant that models the con-
formation of Cytc when bound to cardiolipin. To create
this mutant, 2 residues (Val83 and Gly84) from the loop
containing Met80 were deleted. Through mass spectrom-
etry, this mutant was confirmed to be specifically autoxi-
dized tomethionine sulfoxidewhenpurified in thepresence
ofmolecular oxygen. Functional changes, such as increased
cardiolipin peroxidase activity and Cytc release with
regard to Met80 modifications, were also found with the
Met80Ala-Cytcmutant (119).
CYTc TYROSINE NITRATION
Tyrosinenitration is a PTM that takes place in the presence
of a reaction between superoxide and NO that forms
peroxynitrite, which acts as the nitration agent (120). In
POST-TRANSLATIONAL MODIFICATIONS OF CYTOCHROME c 1547
contrast to phosphorylation, tyrosine nitration is a stable
PTM. It has been estimated that only 1–5 of 10,000 tyrosine
residues are nitrated in a protein under inflammatory
conditions in vivo. Given the very low frequency of this
modification of ,0.1%, mapping nitrated tyrosine resi-
dues has been a challengingprocess (121). The first protein
identified as nitrated in vivo was manganese superoxide
dismutase (122, 123). Human Cytc has 5 tyrosine residues
at sites 46, 48, 67, 74, and 97, of which 4 are evolutionarily
conserved in mammals (61, 124). Of the 5 tyrosine resi-
dues, only 3 (Tyr67, Tyr74, and Tyr97) are nitrated in vitro
in the presence of peroxynitrite (125). Tyr67- and Tyr74-
nitrated Cytc are less efficient in restoring respiratory ca-
pacity in Cytc-deficient mitochondria compared to Tyr97
(125, 126). Tyr48, which is highly conserved, and Tyr46,
which is present only in humans and plants,were the least
commonly nitrated residues (127).
Tyrosine nitration of Cytc has been reported under
several conditions in vivo. In a renal ischemia–reperfusion
model, Cytc was nitrated 3 h after the ischemic insult, as
confirmed by nitrotyrosine immunoprecipitation (128).
Furthermore, an increased release of nitrated Cytc was
observed inbrain tissuesectionsof ratsexposed to ischemia-
reperfusion (129). Another study suggested that tyrosine
nitration of Cytc was induced by chemoradiotherapies,
such as 5-fluorouracil, cis-diaminedicholorplatinum, and
g-rays (130). However, the researchers reported that ni-
tration of Cytc alone does not suppress apoptosis
in squamous cell carcinoma cells, probably because only
a small fraction of Cytc carries the modification. Cytc
nitration was also observed in a rat model of chronic
allograft nephropathy 4 wk after transplantation, sug-
gesting that nitration ofCytc occurs during kidney injury
(131). However, no specific nitration site has been re-
ported under physiological conditions, suggesting that
most of these modifications are relatively nonspecific
and driven by nitro-oxidative stress. Furthermore, some
of the observations reported in vivo do not mirror the
functional studies performed with nitrated Cytc in vitro
because most in vitro studies conclude that nitration
prevents caspase activation (124, 132, 133). This again is
likely to be explained by the small portion of Cytc that is
nitrated in vivo, even under severe stress conditions.
Because tyrosine residues can also be phosphorylated, it
should be noted that tyrosine nitration and phosphory-
lation of the same residue in a protein are mutually
exclusive events (134).
Tyr67 nitration
Several in vitro studies have analyzed peroxynitrite-
mediated nitration of Tyr67 and reported changes in re-
dox function, cardiolipin peroxidation, and respiration
(135, 136). Furthermore, spectrophotometric studies of
Tyr67-nitratedCytchave showna loss of the 695 nmband,
indicating the disruption of the axial Fe-S (Met80) bond.
This finding makes sense because Tyr67 is adjacent to the
hemegroupofCytc andpoints toward theFe-Met80bond.
A study using osteoclasts confirmed Tyr67 nitration by
mass spectrometry (137). Tyr67-nitrated Cytc was then
proposed to be less prone to apoptosis due to intra-
molecular hydrogen bonding that promotes stronger in-
teractions with the cardiolipin phosphates, making Cytc
release less favorable. Cardiolipin peroxidase activity
studies have demonstrated that the Tyr67Phe mutation
leads to a partial loss of peroxidase activity, suggesting
that this conserved tyrosine could be the reactive tyrosyl
radical involved in the oxygenase half reaction of Cytc-
cardiolipin peroxidation (65). Finally, studies with human
Cytc in which all tyrosines except for Tyr67 were replaced
with phenylalanine showed .50% decreased caspase
activation at saturating Cytc concentrations after in vitro
nitration of Tyr67 (126).
Tyr74 nitration
Tyr74 is fully surface exposed and the most commonly
nitrated tyrosine residue inCytc. An in vitro study showed
that Tyr74 nitration results in increased cardiolipin per-
oxidase activity (124). However, thismutant also prevents
downstream caspase-9 activity. Peroxynitrite-mediated
nitration of Tyr74 resulted in a disruption of the axial Fe-S
(Met80) bond andwas replaced by Lys72 as confirmed by
NMR (138). Lys72 is a crucial residue for the interaction of
Cytc with Apaf-1, which may explain the low caspase-9
activity (56). In vitro studies on Met80 sulfoxidation and
Tyr74 nitration suggested that, in the presence of both of
these modifications, the binding affinity for cardiolipin
was 4 times higher thanwithWTCytc (116). Furthermore,
Tyr74 nitration leads to a lower midpoint redox potential,
interfering with electron transfer (139).
Tyr46 and Tyr48 nitration
There is no current evidence of in vivo nitration at Cytc
residues Tyr46 and Tyr48, even though they are solvent
exposed and located close to the heme group that can
catalyze nitration. Tyr46 is only present in human and
plant Cytc, whereas Tyr48 is conserved in Cytc across all
species. In vitro studies showed that Tyr46 and Tyr48 ni-
tration promote the formation of the heme iron penta-
coordinated form, which increases peroxidase activity.
Nitration of these residues also affects the surrounding
heme propionates. Furthermore, the use of monotyrosine
mutants of both sites results in rapid degradation of Cytc
in Jurkat cell extracts, suggesting that these nitrations are
not physiologically favorable (127). The same group also
reported that neither nitration has an effect on the rate of
electron transfer to COX. However, light-scattering ex-
periments have shown that these modifications lead to
poor interactions with Apaf-1, forming a nonfunctional
apoptosome and reducing caspase-9 activity (133). Even
though Tyr sites 74, 46, and 48 result in a reduction in
caspase activity, most in vivo studies suggest that Cytc
nitration is associated with increased apoptosis and mi-
tochondrial dysfunction (128–131). As discussed above,
the low stoichiometries of Tyr nitration in in vivo condi-
tions make their biological effect debatable. In fact, Cytc
tyrosine nitration may be a good model system to study
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the effect of phosphorylation related to the introduction of
a negative charge and spatial requirements that are similar
to those of a phosphate group. Looking at tyrosine nitra-
tion from this angle, it may not be surprising that in vitro
data for tyrosine phosphorylation and nitration, as well
as phosphomimetic substitution, show mostly consis-
tent results.
CYTc NITROSYLATION
Nitrosylation involves the addition of anNO group to a
free cysteine or a transition metal. Therefore, it takes
place in a limited number of proteins in vivo (140, 141).
Because Cytc has no free cysteines, its only target of
nitrosylation is the heme group. A few studies have
shown thatCytc can be nitrosylated in vitro and inU-937
monocytic cells (142–144). Nitrosylated Cytcwas found
to be mostly present in the cytosol. However, when
antiapoptotic proteins such as Bcl-2 and -XL were
overexpressed, most of the nitrosylated Cytc was
found in the mitochondria. The researchers concluded
that nitrosylation of Cytc may play a role in apoptosis
regulation (144). Endogenous heme nitrosylation is a
fairly rare event that is observed in only a few other
proteins, such as COX and guanylyl cyclase, the only
known receptor for NO (145–148). In both COX and
guanylyl cyclase, the heme iron is pentacoordinated,
unlike in Cytc, where it is hexacoordinated (149). Because
Cytc can undergo a conformational change into a
pentacoodinated form, it may be nitrosylated in condi-
tions when the Fe-S (Met80) bond is displaced, leading
to greater cardiolipin peroxidase activity.
CONCLUSIONS
Cytc plays a significant role in balancing cellular life- and
death-related functions. Both the primary functions of
Cytc—respiration leading to energy production and apo-
ptosis leading to cell death—are regulated to meet tissue-
andorgan-specificneeds.Therefore,Cytchas tissue-specific
phosphorylations that regulate respiration, apoptosis,
and ROS production and scavenging. For instance, the
liver-specific Tyr48 phosphorylation abolishes apopto-
sis, which is sensible, given that liver cells are exposed to
toxic molecules primarily through food uptake. There-
fore, these cells have a higher threshold for cell death
commitment, supporting the concept that Tyr48 is an
important regulatory site for apoptosis. In contrast, the
Thr28 phosphorylation observed in kidney results in the
same level of apoptotic activity as unmodified WT Cytc,
suggesting that an apoptosis-suppressing mechanism is
not needed in this organ. However, Thr28 phosphory-
lation and all other phosphorylations studied to date
indirectly protect the tissues from ROS damage where
they are found by reducing mitochondrial respiration
and thus the DCm. Maintenance of intermediate DCm
prevents excessive ROS generation but allows efficient
energy production. However, during cellular stress such
as ischemia-reperfusion,which is found under pathologic
conditions in many organs including the heart, kidney,
and brain, Cytc becomes dephosphorylated, resulting in
DCm hyperpolarization (.140 mV) during reperfusion
and a consequent burst of ROS, adding to the tissue
damage and death already generated during the ischemic
phase (Fig. 4).
When interpreting the biological significance of PTMs
identified on Cytc the stoichiometry has to be considered.
Some PTMs such as nitrations of Cytc have been reported
under several pathological conditions. These modifica-
tions tend to take place in a nonspecificmanner and can be
attributed as spontaneous chemical reactions to nitro-
oxidative stress. Inmammals, under normal physiological
conditions only tissue-specific phosphorylation of Cytc
has exceeded 50% of the Cytc pool. Methylation of Cytc,
even though important in yeast and plants, has not been
reported to be physiologically relevant in mammalian
species. Acetylation could be an interesting regulatory
modification given that the mammalian mitochondrial
proteome is highly acetylated, and a specific Cytc acety-
lation site has been identified in mouse liver of unfed
animals. In the future, an in-depth understanding of
PTMs of Cytcwill necessitate the identification of signal-
ing molecules, including kinases, phosphatases, and
scaffoldingproteins, thatmediate cell signaling ina tissue-
specific manner.
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